UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000047691
Receipt No. R000054373
Scientific Title Analysis of predicted factors in severe COVID-19 and the other viral infected patients.
Date of disclosure of the study information 2022/05/09
Last modified on 2022/05/09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Analysis of predicted factors in severe COVID-19 and the other viral infected patients.
Acronym Predicted factors in severe COVID-19
Scientific Title Analysis of predicted factors in severe COVID-19 and the other viral infected patients.
Scientific Title:Acronym Predicted factors in severe COVID-19
Region
Japan

Condition
Condition COVID-19 and viral pneumonia
Classification by specialty
Medicine in general Infectious disease
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Analysis of predicted factors in severe COVID-19 and the other viral infected patients.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Analysis of predicted factors in severe COVID-19 and the other viral infected patients.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria COVI-19 and other viral diseases
Low oxygen
Viral pneumonia
Accept the IC
Key exclusion criteria Not accept the IC
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Masafumi
Middle name
Last name Seki
Organization Saitama Medical University, International Medical Center
Division name Division of Infectious Diseases and Infection Control
Zip code 350-1298
Address Yamane 1397-1, Hidaka City, Saitama, Japan
TEL 0429844392
Email sekimm@saitama-med.ac.jp

Public contact
Name of contact person
1st name Masafumi
Middle name
Last name seki
Organization Saitama Medical University, International Medical Center
Division name Division of Infectious Diseases and Infection Control
Zip code 350-1298
Address Yamane 1397-1, Hidaka City, Saitama, Japan
TEL 0429844392
Homepage URL
Email sekimm@saitama-med.ac.jp

Sponsor
Institute Saitama Medical University, International Medical Center
Institute
Department

Funding Source
Organization Saitama Medical University, International Medical Center
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Saitama Medical University, International Medical Center
Address Yamane 1397-1, Hidaka City, Saitama, Japan
Tel 0429844392
Email sekimm@saitama-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 05 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 05 Month 09 Day
Date of IRB
Anticipated trial start date
2022 Year 06 Month 01 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information None

Management information
Registered date
2022 Year 05 Month 09 Day
Last modified on
2022 Year 05 Month 09 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054373

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.